The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase Ib study of a high potent PI3K-mTOR dual inhibitor WX390 combined with toripalimab in patients with advanced solid tumors.
 
Songling Zhang
No Relationships to Disclose
 
Xiaoxue Zhu
No Relationships to Disclose
 
Lei Gao
No Relationships to Disclose
 
Yaling Qi
Employment - Shanghai Jia Tan Pharmatech
Leadership - Shanghai Jia Tan Pharmatech
Honoraria - Shanghai Jia Tan Pharmatech
 
Xiao Jia
Employment - Shanghai Jia Tan Pharmatech
Honoraria - Shanghai Jia Tan Pharmatech
 
Yongguo Li
Employment - Shanghai Jia Tan Pharmatech
Leadership - Shanghai Jia Tan Pharmatech
Stock and Other Ownership Interests - Shanghai Jia Tan Pharmatech
Honoraria - Shanghai Jia Tan Pharmatech
Patents, Royalties, Other Intellectual Property - Shanghai Jia Tan Pharmatech
 
Ye Guo
Honoraria - BeiGene; Merck Serono; MSD; Roche
Consulting or Advisory Role - GlaxoSmithKline; Merck Serono; MSD; Roche
 
Yanhua Ding
No Relationships to Disclose